News Archives - Page 5 of 1469

TuesdayJul 22, 2025 3:44 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Host Investor Webinar Highlighting RedTail Platform and Oncology Advancements

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech company developing targeted genetic medicine therapies, will host an investor webinar on July 24, 2025, at 4:15 p.m. ET. Led by CEO Eric Poma, Ph.D., the event will showcase Calidi’s RedTail(TM) platform, a systemically delivered viral therapy designed to treat metastatic tumors by evading immune detection. Preclinical data on lead candidate CLD-401 showed tumor elimination and immune memory activation. The company is progressing toward an IND filing and pursuing strategic pharma partnerships to support commercialization. A Q&A session will follow the presentation. To view the full press release, visit https://nnw.fm/cojf9 About Calidi…

TuesdayJul 22, 2025 3:29 pm

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Featured in NetworkNewsWire Editorial Amid Gold Price Surge

NetworkNewsWire editorial titled “Gold Rally Intensifies as Juniors Race Toward Production.” The article highlights gold’s rise past $3,300 per ounce in 2025 and investor flight to hard assets. LaFleur, with a permitted mill and advanced-stage exploration project in Quebec, is positioned to become one of the region’s next gold producers, aligning with market momentum and regional support for mining development. To view the full press release, visit https://nnw.fm/STtFy About LaFleur Minerals Inc. LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) is focused on the development of district-scale gold projects in the Abitibi Gold Belt near Val-d'Or, Québec. Our mission…

TuesdayJul 22, 2025 3:17 pm

NetworkNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Makes $1.5 Million Option Payment Toward Iska Iska Acquisition

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) has made a US$1.5 million option payment to Empresa Minera Villegas S.R.L., advancing its acquisition of the Iska Iska silver-tin polymetallic project in southern Bolivia. One final cash payment of US$1.15 million remains, due January 6, 2026. Under amended terms, Eloro’s US$10 million option agreement includes a US$1.8 million credit for exploration work on the nearby Mina Casiterita property. To secure full ownership of Mina Casiterita and Mina Hoyada, Eloro must pay US$1.8 million within 12 months of obtaining mining rights and, pending regulatory approvals, issue 200,000 common shares upon property transfer.…

TuesdayJul 22, 2025 2:25 pm

NetworkNewsBreaks – Roth Capital Partners, LLC Announces Closing of Silver Pegasus Acquisition Corp. (NASDAQ: SPEGU) $115 Million IPO Including Full Over-Allotment Exercise

Roth Capital Partners acting as sole manager, today announced the closing of the $115 million initial public offering for Silver Pegasus Acquisition Corp. (NASDAQ: SPEGU), a special purpose acquisition company. The offering, which closed July 16, 2025, included the full exercise of the underwriters’ over-allotment option, totaling 11,500,000 units at $10.00 per unit. Each unit consists of one Class A ordinary share and one right to receive one-tenth of a Class A share upon the consummation of a business combination. The units began trading on Nasdaq on July 15 under the symbol “SPEGU.” The offering was made only by means…

TuesdayJul 22, 2025 2:10 pm

NetworkNewsBreaks – Quant Strats 2025 to Explore Tech-Driven Investing in Real-Time Markets

Quant Strats Europe 2025, returning to London on Oct. 14–15, will unite over 600 leading professionals from quantitative finance to reflect on a volatile year in global markets and explore the future of data-driven investing. With speakers from firms like BlackRock, Man Group, Millenium Global, and Deutsche Bank, the two-day event will spotlight AI integration, data science advancements, LLMs, NLP, and evolving risk frameworks. The event will feature case studies, academic insights, and deep dives into portfolio construction and operational efficiency. Set against a backdrop of market uncertainty and rapid tech transformation, the event aims to provide critical insight and…

TuesdayJul 22, 2025 1:44 pm

NetworkNewsBreaks – BluSky AI Inc. (OTC: BSAI) Appoints Andrea Huels as Chief AI and Growth Officer to Lead Modular Infrastructure Expansion

BluSky AI (OTC: BSAI), a leader in modular AI infrastructure, has named Andrea Huels as its new Chief AI and Growth Officer. Huels, a recognized authority in applied AI and edge computing, brings over 20 years of leadership across Fortune 500 companies and startups, including Lenovo, GE, and RadiusAI. She will drive BluSky’s AI strategy, ecosystem growth, and the expansion of its SkyMod modular data center platform. CEO Trent D’Ambrosio said Huels' arrival “marks a defining moment” for the company’s next phase of growth. To view the full press release, visit https://nnw.fm/COCFE About BluSky AI Inc. BluSky AI, headquartered in…

TuesdayJul 22, 2025 1:26 pm

NetworkNewsBreaks – ECGI Holdings Inc. (OTC: ECGI) Joins TCA Venture Group as Affiliate to Expand Early-Stage Deal Flow

ECGI Holdings (OTC: ECGI) a diversified holding company, announced that its investment division, Uplist Ventures, has joined TCA Venture Group (formerly Tech Coast Angels) as an affiliate member. The affiliation grants Uplist Ventures access to one of the nation’s most active angel investor networks, which has backed 545 companies with $280 million and yielded 126 exits. ECGI aims to leverage this relationship to identify Series A and B investments, support rollup strategies, and prepare portfolio companies for future IPOs. CEO Simon Yu called the move “a window into deals that can accelerate our growth ambitions.” To view the full press…

TuesdayJul 22, 2025 1:07 pm

NetworkNewsBreaks – The Latest in Trading and Innovation to Converge in Johannesburg

The 2025 Traders Fair is heading to Johannesburg on Sept. 20, promising a dynamic fusion of global trading expertise and local market insight. Hosted at the Protea by Marriott Hotel Johannesburg Wanderers in Sandton, the event will feature renowned sponsors, including XS.com, Trading Pro, InstaForex, and GTC FX, bringing the latest in financial tools, education, and opportunities. From product showcases to interactive exhibits, the fair offers a full day of professional development, networking, and celebration for all those passionate about trading and investing. To view the full article, visit https://nnw.fm/VVdse About Traders Fair South Africa Traders Fair 2025 offers a…

TuesdayJul 22, 2025 12:45 pm

NetworkNewsBreaks – Exciting Industry Trends to Take the Stage at Traders Fair Hong Kong

Traders Fair Hong Kong is returning to one of Asia’s most influential financial hubs on Dec. 10, 2025, at the luxurious Kerry Hotel Hong Kong by Shangri-La. Organized by iEvents, the fair will showcase leading voices and top brands, providing traders, investors, brokers, fintech companies, and financial institutions the opportunity to engage, exhibit, and explore the latest industry trends. The iconic Victoria Harbour will provide the backdrop for the immersive event offering countless opportunities for meaningful networking, connection, and insight into the innovative future of trading. To view the full article, visit https://nnw.fm/z1YUp About Traders Fair Hong Kong Traders Fair…

TuesdayJul 22, 2025 11:15 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Virtual Investor Summer Spotlight Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for cancers of the brain and central nervous system, announced that CEO John Climaco participated in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference. Climaco shared his personal journey, leadership vision and enthusiasm for the company’s development programs. The webcast is available on virtualinvestorco.com and the Events section of the CNS Pharmaceuticals website. To view the full press release, visit https://nnw.fm/Mpiit About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Breaks Categories: News